ZOZENTI

View On IPO.GOV.AU

Cancelled: Cancelled at the request of IB

Last updated on 9 Feb 2017

Owner Info

Syndax Pharmaceuticals, Inc.

400 Totten Pond Road, Suite 110

Waltham MA 02451, UNITED STATES OF AMERICA

Serial Number

1702709 filed on 22 Jan 2015

Correspondent

Jennifer M. Lantz, Hogan Lovells US LLP

4085 Campbell Avenue, Suite 100,

Menlo Park CA 94025,

UNITED STATES OF AMERICA

ZOZENTI

Classification Information

1702709

22 Jan 2015

WORD

13 Nov 2014

Status Date	Action Taken
9^th Feb 2017	Cancellation of Entry in Register Published
2^th Feb 2017	Cancel IP Right
29^th Sept 2016	General Correspondence (Application or Registration)
8^th Oct 2015	IP Right Registration Published
1^st Oct 2015	Register Trade Mark
1^st Oct 2015	Application Status
23^rd Jul 2015	IP Right Acceptance Published
15^th Jul 2015	Clear Examination report approved
15^th Jul 2015	User Created Notice correspondence sent
15^th Jul 2015	Application Accepted correspondence sent